Asia Fresh News

Asia Fresh Stories

ASX-Listed Holista CollTech Brings Revolutionary Injection-Free “Botox-Like” Geltox Skin Science to Asia Pacific

leave a comment »

-To Develop Cosmetic Range Based on Proprietary Sheep Collagen

KUALA LUMPUR, Malaysia /PRNewswire/ — Australian-listed Holista CollTech Ltd (“Holista”; ASX: HCT) said today that it has secured Asia Pacific distribution rights for Geltox Skin Science, a breakthrough solution that produces a “botox-like” effect to reduce or remove skin wrinkles using plant extracts  without the need for injections.

Geltox Skin Science has developed tiny water- and fat-soluble liposomes that can penetrate the skin. The liposomes coat and transport anti-ageing active ingredients that increase efficiency and lower toxicity of the encapsulated ingredients which, after penetration, are absorbed and diffused better in the body  minus the pain and hassle of syringes and needles requiring qualified professionals.

Developed by Spain-based Palma Biotech, patent-pending Geltox Skin Science uses a combination of plant-based peptides to cause mild paralysis in specific muscles reducing facial expression lines including frowns. Similar to Botox®, the effects are immediate upon application and, over time, remove the lines altogether  except injection is no longer required.

Palma Biotech, a specialist in liposomes and liposomal encapsulation technologies, works with different active compounds that can be paired with its Liposome expertise. Holista, which distributes supplements, natural ingredients and wellness products, has developed and patented its own sheep collagen. Along with the distribution rights, Holista intends to collaborate with Geltox Skin Science to develop sheep collagen liposomes for cosmetic applications.

“Geltox Skin Science is a breakthrough technology which has many applications for cosmetics and even medical use. By eradicating the need for injections, it offers a pain-free alternative which will gain wide acceptance across the region, including younger men and women. Beyond our existing range of sheep collagen, we now have a new avenue of growth with a unique technology,” said Dr. Rajen Manicka, CEO of Holista which is headquartered in Kuala Lumpur, Malaysia.

Mr. Frode Thengs-Vik, the CEO and Co-Founder of Palma Biotech, said, “The product is registered, approved and used in Europe. It is manufactured as per standards of the European Union.”

“We are pleased to have found an Australian partner that can take our unique innovation to the Asian Pacific region which is now one of the most dynamic markets in the world,” said Mr. Olav Hellebo, Chairman of the Board and Co-Founder of Palma Biotech.

Business Enquiries:

Media Enquiries:
WeR1 Consultants
Ms. Sheryl Sim;

Source: Holista Colltech

Related stocks: Australia:HCT

Written by asiafreshnews

April 30, 2015 at 4:10 pm

Posted in Uncategorized

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: